Kits Eyecare Statistics
Total Valuation
Kits Eyecare has a market cap or net worth of CAD 622.95 million. The enterprise value is 597.26 million.
| Market Cap | 622.95M |
| Enterprise Value | 597.26M |
Important Dates
The last earnings date was Thursday, November 5, 2026.
| Earnings Date | Nov 5, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Kits Eyecare has 33.97 million shares outstanding. The number of shares has increased by 0.21% in one year.
| Current Share Class | 33.97M |
| Shares Outstanding | 33.97M |
| Shares Change (YoY) | +0.21% |
| Shares Change (QoQ) | -0.09% |
| Owned by Insiders (%) | 26.00% |
| Owned by Institutions (%) | 16.94% |
| Float | 14.64M |
Valuation Ratios
The trailing PE ratio is 140.90 and the forward PE ratio is 66.98.
| PE Ratio | 140.90 |
| Forward PE | 66.98 |
| PS Ratio | 2.72 |
| PB Ratio | 8.52 |
| P/TBV Ratio | 19.38 |
| P/FCF Ratio | 56.47 |
| P/OCF Ratio | 45.21 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 60.96, with an EV/FCF ratio of 54.18.
| EV / Earnings | 139.33 |
| EV / Sales | 2.61 |
| EV / EBITDA | 60.96 |
| EV / EBIT | 77.29 |
| EV / FCF | 54.18 |
Financial Position
The company has a current ratio of 1.72, with a Debt / Equity ratio of 0.07.
| Current Ratio | 1.72 |
| Quick Ratio | 0.94 |
| Debt / Equity | 0.07 |
| Debt / EBITDA | 0.49 |
| Debt / FCF | 0.44 |
| Interest Coverage | 17.85 |
Financial Efficiency
Return on equity (ROE) is 6.40% and return on invested capital (ROIC) is 10.02%.
| Return on Equity (ROE) | 6.40% |
| Return on Assets (ROA) | 4.62% |
| Return on Invested Capital (ROIC) | 10.02% |
| Return on Capital Employed (ROCE) | 9.95% |
| Weighted Average Cost of Capital (WACC) | 6.95% |
| Revenue Per Employee | 1.33M |
| Profits Per Employee | 24,813 |
| Employee Count | 176 |
| Asset Turnover | 2.19 |
| Inventory Turnover | 6.00 |
Taxes
In the past 12 months, Kits Eyecare has paid 2.54 million in taxes.
| Income Tax | 2.54M |
| Effective Tax Rate | 36.77% |
Stock Price Statistics
The stock price has increased by +35.93% in the last 52 weeks. The beta is 0.49, so Kits Eyecare's price volatility has been lower than the market average.
| Beta (5Y) | 0.49 |
| 52-Week Price Change | +35.93% |
| 50-Day Moving Average | 16.97 |
| 200-Day Moving Average | 15.25 |
| Relative Strength Index (RSI) | 52.29 |
| Average Volume (20 Days) | 81,079 |
Short Selling Information
The latest short interest is 14,456, so 0.05% of the outstanding shares have been sold short.
| Short Interest | 14,456 |
| Short Previous Month | 16,245 |
| Short % of Shares Out | 0.05% |
| Short % of Float | 0.18% |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Kits Eyecare had revenue of CAD 233.48 million and earned 4.37 million in profits. Earnings per share was 0.13.
| Revenue | 233.48M |
| Gross Profit | 88.31M |
| Operating Income | 7.87M |
| Pretax Income | 6.91M |
| Net Income | 4.37M |
| EBITDA | 8.99M |
| EBIT | 7.87M |
| Earnings Per Share (EPS) | 0.13 |
Balance Sheet
The company has 30.63 million in cash and 4.94 million in debt, with a net cash position of 25.69 million or 0.76 per share.
| Cash & Cash Equivalents | 30.63M |
| Total Debt | 4.94M |
| Net Cash | 25.69M |
| Net Cash Per Share | 0.76 |
| Equity (Book Value) | 74.47M |
| Book Value Per Share | 2.19 |
| Working Capital | 25.35M |
Cash Flow
In the last 12 months, operating cash flow was 14.03 million and capital expenditures -2.80 million, giving a free cash flow of 11.23 million.
| Operating Cash Flow | 14.03M |
| Capital Expenditures | -2.80M |
| Depreciation & Amortization | 1.12M |
| Net Borrowing | -3.04M |
| Free Cash Flow | 11.23M |
| FCF Per Share | 0.33 |
Margins
Gross margin is 37.82%, with operating and profit margins of 3.37% and 1.87%.
| Gross Margin | 37.82% |
| Operating Margin | 3.37% |
| Pretax Margin | 2.96% |
| Profit Margin | 1.87% |
| EBITDA Margin | 3.85% |
| EBIT Margin | 3.37% |
| FCF Margin | 4.81% |
Dividends & Yields
Kits Eyecare does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -0.21% |
| Shareholder Yield | -0.21% |
| Earnings Yield | 0.71% |
| FCF Yield | 1.77% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside | |
| Graham Formula Value | |
| Graham Formula Upside |
Analyst Forecast
The average price target for Kits Eyecare is 23.79, which is 29.72% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | 23.79 |
| Price Target Difference | 29.72% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 7 |
| Revenue Growth Forecast (3Y) | 18.00% |
| EPS Growth Forecast (3Y) | 59.04% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Kits Eyecare has an Altman Z-Score of 10.05 and a Piotroski F-Score of 7.
| Altman Z-Score | 10.05 |
| Piotroski F-Score | 7 |